Summary
Updated Aug 31, 2026
Merdad Parsey is Director of ArriVent BioPharma, Inc. (AVBP). 6 SEC Form 4 filings on record going back to 2024, most recently on 23 June 2026. Most recent open-market trade: sold $957K of GILD on 29 November 2024. Lifetime open-market sales: $17.60M.
Recent Transactions
14Every recent SEC Form 4 transaction Merdad Parsey has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Merdad Parsey go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 5 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Merdad Parsey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. - $12.98M of AVBP open-market activity in the last 12 months
- Michael Raab - $2.57M of ARDX open-market activity in the last 12 months
- David M. Mott - $1.95M of ARDX open-market activity in the last 12 months
- Laura A. Williams - $659K of ARDX open-market activity in the last 12 months
- Eric Duane Foster - $176K of ARDX open-market activity in the last 12 months
- Mike Kelliher - $162K of ARDX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Merdad Parsey?
Merdad Parsey is a corporate insider, tracked as Director of ArriVent BioPharma, Inc. (AVBP). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Merdad Parsey submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Merdad Parsey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($17.60M) across all tracked filings.
Where can I see all of Merdad Parsey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Merdad Parsey and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial